Search Press releases Keywords From To 9 Oct 2024 Transparency notification BlackRock, Inc. Read More 3 Oct 2024 Transparency notification BlackRock, Inc. Read More 1 Oct 2024 Transparency notification BlackRock, Inc. Read More 30 Sep 2024 Transparency notification BlackRock, Inc. Read More 30 Sep 2024 UCB announces a head-to-head study evaluating BIMZELX[®]▼(bimekizumab) versus SKYRIZI® (risankizumab) in active psoriatic arthritis Read More 27 Sep 2024 Transparency notification BlackRock, Inc. Read More Pagination First page Previous page Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Page 8 of 68 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
